A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D745 and D150

NCT04334213 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: CKD-501
DRUG: D745, D150
DRUG: CKD-501, D745, D150

Sponsor

Chong Kun Dang Pharmaceutical